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In cystic ﬁbrosis (CF) patients, recent data suggest that Interferon related de-
velopmental regulator 1 (IFRD1) is a modiﬁer gene for lung disease. IFRD1
acts in a histone-deacetylase (HDAC)-dependent manner to mediate transcriptional
co-repression of NF-úB transactivation involved in inﬂammation. We therefore
hypothesize that intrinsic alterations might occur in the balance of HDAC1−3 and
IFRD1 expression in CFTR-deﬁcient cells compared to normal and corrected CF
airway cells.
We have examined the expression level of three HDAC1,2,3 mRNA and IFRD1
mRNA (by qPCR) in two CF bronchial cell lines (IB3−1 and CFBE41o−) compared
to CFTR-corrected and sufﬁcient (S9 and 16HBE14o−) cell models. We also
evaluated the level of HDACs1−3 proteins by Western blotting and measured the
total HDACs enzymatic activity under oxidative stress (IL-1b, 10 ng/ml and/or
H2O2, 100 and 500 mM, 1 h).
First, we show a lowest expression of HDACs(1−3) and IFRD1 mRNA in
CFBE41o− cells compared to 16HBE14o− cells. We observe that the level of
HDACs(1−3) proteins and particularly HDAC2 is reduced in CFTR-deﬁcient
cells compared to CFTR-sufﬁcient cells in response to oxidative stress. We also
demonstrate that total HDAC activity was lower in IB3−1 and CFBE41o− cells
compared to S9 and 16HBE14o− cells at both basal and oxidative stress conditions.
Together, our data show signiﬁcant difference in the HDAC1−3/IFRD1 signaling
in CFTR deﬁcient cells compared to normal and corrected CF airway cells.
Understanding how loss of CFTR function leads to alterations in the regulation
of IFRD1/HDACs complex and its role in exaggerated inﬂammatory response in
CF airway cells require further investigation.
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Background: The T-cell immunoglobulin and mucin-domain containing molecules
(TIMs) constitute a new receptor protein family involved in regulation of immune
responses. However, the role of TIM receptors in cystic ﬁbrosis (CF) is unknown.
The aim of this study was to examine the expression of TIM receptors in the CF
airway epithelium.
Methods: We examined the expression of TIM-1 and TIM-3 in CF airway epithelial
cells using real-time reverse transcriptase-polymerase chain reaction (RT-PCR),
laser scanning microscopy and Western blotting. Cell surface expression of TIM-3
was conﬁrmed by membrane surface biotinylation and immunoﬂuorescence con-
focal microscopy. We also investigated the effect of the pro-inﬂammatory stimuli,
lipopolysaccharide (LPS), on TIM expression.
Results: Our results demonstrate that TIM-1 and TIM-3 are expressed in human
bronchial epithelial cells. We also show that TIM-1 and TIM-3 are signiﬁcantly
upregulated in quiescent CF cells, implying a role for the cystic ﬁbrosis transmem-
brane conductance regulator channel in TIM expression. Finally, our experiments
revealed that TIM-3 expression can be modulated by pro-inﬂammatory stimuli. LPS
treatment induced a 3-fold increase in TIM-3 expression in CF cells versus 2-fold
increase in controls (p< 0.001).
Conclusions: Our work reports for the ﬁrst time, the expression of TIM receptors
in human bronchial epithelial cells. The upregulation of TIM-1 and TIM-3 may
represent a novel intrinsic defect that contributes to the aberrant immune response
in the CF airway.
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The T3SS of P. aeruginosa (P.a.) is recognized to be an important cause of death
during acute lung infection. However, the role of T2SS in this process has not been
conclusively demonstrated. Using TLR2,4 −/− mutant mice and ﬂagellin negative
mutant strains of P.a., essentially abrogating the major innate immune responses
against LPS and ﬂagellin, we unequivocally demonstrate that these toxin secretion
systems play redundant roles in death from acute lung infections. We challenged
TLR2,4 −/− mice with T2 and T3SS mutants of strain PAK with a ﬂagellin gene
mutation. Mice were observed for mortality or sacriﬁed to measure host inﬂam-
matory responses and bacterial counts and for histological studies. Strains having
only T3SS killed mice within 24 h. Strains with only the T2SS also killed mice,
but with a delay. Strains lacking both secretion systems were avirulent. Histological
studies demonstrated a delayed onset of pathological lesions that progressed with
time, when the T2SS was the sole system present. Minimal inﬂammation, which did
not progress, was noted when both secretion systems were absent. In the absence
of both secretion systems the mice cleared the microorganisms in 44 h, by contrast
when the T2SS was intact, bacterial counts at 37−44 h had increased. These data
demonstrate that the T2SS of P.a. also plays a role in death due to lung infections,
and that this system secretes factors that impair bacterial clearance, besides causing
death. This work also suggests that in this strain of P.a. and this animal model, the
non T2/T3SS do not contribute signiﬁcantly to death.
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Background: Modifying genes of innate immunity may be involved in the early
onset of chronic Pa colonization (CPaC) in CF.
Methods: 82 Single Nucleotide Polymorphisms (SNPs) in 22 genes contributing
to innate immunity [MBL2, MASP (MBL-associated serine Protease)1/2/3, FCN
(Ficolin)1/2, LBP (Lipopolysaccharide-binding Protein), CD14, TLR (Toll-like
receptors 1→ 10)] were genotyped in an initial cohort of 116 CF patients and
later expanded to 215 CF patients. The frequency of SNPs was compared between
2 subgroups: CPaC patients versus non colonized patients and CPaC patients
colonized before/or at the age of 8, 10 and 12 years (y) versus CPaC patients
colonized older than 8, 10 and 12 y.
Results: In CPaC patients an increased frequency of polymorphism −1981(A>G)
FCN1 (promoter) (Odds ratio [OR] = 2.87 [95% conﬁdence interval (CI):
1.21−6.8] p = 0.01) and polymorphism Q275Q (G>A) FCN1 (OR= 3.31 [1.40–
7.85] p = 0.005) was found compared to non Pa colonized patients. Looking at the
age of onset of Pa colonization, L617L(G>A) polymorphism of MASP3 (OR= 4.38
[1.37–14.02] p = 0.009), −64A>C polymorphism FCN2 (promoter) (OR= 5.63
[1.63–19.42] p = 0.003) and S258A(X>Y) polymorphism FCN2 (OR= 6.62 [1.91–
22.89] p = 0.001) were signiﬁcantly more common in CPaC patients colonized
before/or at 10 y compared to those colonized older than 10 y. In the larger group,
S258A in FCN2 remained more common in CPaC patients colonized younger than
or equal to 10 y (OR= 3.2 [1.22–8.46] p = 0.01).
Currently, we are performing Multifactor Dimensionality Reduction for detecting
interactionsin SNPs.
Conclusion: Polymorphisms L617L of MASP3,−64A>C and S258A of FCN2 are
signiﬁcantly more common in CPaC patients colonized at a younger age.
